Global Contraceptive Device Market Size By Type (Male Contraceptive Devices, Female Contraceptive Devices), By Application (Hospital Pharmacy, Independent Pharmacy), By Region, And Segment Forecasts,...

The Global Contraceptive Device Market was valued at USD 11.3 billion in 2023 and is projected to reach USD 18.7 billion by 2031, expanding at a CAGR of 6.7% during the forecast period from 2023 to 2031. The rising awareness of family planning, the growing global population, increased government initiatives for birth control, and the availability of a broad range of products are key drivers of market growth. Technological advancements in intrauterine devices (IUDs), contraceptive implants, and barrier methods are reshaping the market landscape and improving accessibility and efficacy, particularly in developing nations.

Drivers:

1. Increasing Awareness and Government Initiatives:

Governments and NGOs across the world are promoting birth control and safe sexual practices through campaigns and subsidies. These initiatives have increased access to contraceptive devices, especially in low-income and high-population countries.

2. Technological Innovations in Contraceptive Devices:

The market is witnessing a surge in demand for next-generation IUDs, biodegradable implants, and hormone-free contraceptives, providing enhanced effectiveness with fewer side effects.

3. Rise in Unintended Pregnancies:

According to global health statistics, the rate of unintended pregnancies continues to be high, propelling the demand for effective and long-term contraceptive solutions.

Restraints:

1. Cultural and Religious Barriers:

In several regions, cultural stigma and religious opposition to contraceptive use limit product adoption, especially among women and adolescents.

2. Side Effects and Health Concerns:

Concerns regarding hormonal imbalances, bleeding disorders, and other side effects deter some users from adopting contraceptive devices.

Opportunity:

1. Growth in Emerging Markets:

Asia-Pacific, Latin America, and parts of Africa are poised for significant growth due to improving healthcare infrastructure and increased governmental support for reproductive health programs.

2. Male Contraceptive Innovations:

Ongoing research into reversible and non-hormonal male contraceptive devices represents a promising opportunity to diversify the market and enhance adoption rates among both genders.

Market by System Type Insights:

Based on system type, the Intrauterine Devices (IUDs) segment accounted for the largest market share in 2023. IUDs are long-acting reversible contraceptives that provide high efficacy and convenience. Their growing popularity stems from reduced maintenance, minimal side effects, and cost-effectiveness over the long term.

Barrier devices like condoms also represent a substantial share due to their dual role in preventing pregnancy and sexually transmitted infections (STIs), while contraceptive implants are anticipated to witness the fastest growth due to their rising adoption in low-income regions through public health initiatives.

Market by End-use Insights:

The Hospitals and Clinics segment dominated the global contraceptive device market in 2023, owing to the increasing preference for professional guidance and procedural insertion of long-term devices like IUDs and implants. Additionally, home care settings are gaining traction with over-the-counter availability of barrier methods and fertility tracking devices, offering privacy and convenience to users.

Market by Regional Insights:

North America held the largest share of the contraceptive device market in 2023 due to high awareness, established healthcare infrastructure, and widespread access to advanced contraceptive options. Meanwhile, Asia-Pacific is expected to experience the highest growth rate during the forecast period, driven by rising population control initiatives, increasing female literacy, and expanding distribution networks in countries such as India, China, and Indonesia.

Competitive Scenario:

Key players operating in the global contraceptive device market include:

Bayer AG

CooperSurgical, Inc.

Teva Pharmaceutical Industries Ltd.

Meril Life Sciences Pvt. Ltd.

DKT International

Reckitt Benckiser Group plc

Veru Inc.

Church & Dwight Co., Inc.

Pregna International Ltd.

Mayer Laboratories, Inc.

These companies are focusing on launching new products, obtaining regulatory approvals, and entering strategic partnerships to expand their global footprint.

Scope of Work – Global Contraceptive Device Market

Report Metric Details

Market Size (2023) USD 11.3 billion

Projected Market Size (2031) USD 18.7 billion

CAGR (2023–2031) 6.7%

Market Segments System Type (IUDs, Implants, Barrier Methods), End-Use (Hospitals & Clinics, Home Care), Region (North America, Europe, Asia-Pacific, Latin America, MEA)

Growth Drivers Government support, technological innovation, increased awareness

Opportunities Growth in emerging markets, male contraceptive development

Key Market Developments:

2023: Bayer AG launched a new generation of hormone-free IUDs with extended effectiveness up to 10 years.

2024: CooperSurgical, Inc. announced the acquisition of a startup specializing in smart fertility tracking devices for home users.

2025: Veru Inc. began clinical trials for a novel, non-hormonal male contraceptive device with reversible functionality.

FAQs:

1. What is the current market size of the Global Contraceptive Device Market?

The market was valued at USD 11.3 billion in 2023.

2. What is the major growth driver of the Global Contraceptive Device Market?

The primary growth driver is increasing awareness and government initiatives promoting family planning and reproductive health.

3. Which is the largest region during the forecast period in the Global Contraceptive Device Market?

North America is the largest region by market share.

4. Which segment accounted for the largest market share in Global Contraceptive Device Market?

The Intrauterine Devices (IUDs) segment held the largest share in 2023.

5. Who are the key market players in the Global Contraceptive Device Market?

Major players include Bayer AG, CooperSurgical, Teva Pharmaceuticals, Meril Life Sciences, and DKT International.